AAL

Seagen Stock Boosted on Billion-Dollar Buyout

SGEN is trading at two-year highs

Deputy Editor
Mar 13, 2023 at 11:41 AM
facebook X logo linkedin


Seagen Inc (NASDAQ:SGEN) stock is soaring today, after news that Pfizer (PFE) is acquiring the company for roughly $43 billion, expanding its access to cancer treatment. At last glance, SGEN was up 15.8% at $199.92, earlier hitting a two-year high of $200. 

On the charts, Seagen stock has experienced a few bull gaps since the start of the year, now up about 55% year-to-date. The security is now above all significant short- and long-term daily moving averages, including its 40-day trendline, which acted as support for the first couple months of the year. 

Options traders are chiming in on the news, with 4,268 calls and 2,426 puts exchanged so far, which is eight times the intraday average. The May 200 call is the most active contract, with new positions being bought to open there. 

Meanwhile, 14 of the 20 analysts in coverage carry a "buy" or better rating on SGEN. The 12-month consensus price target of $174.95 was close to the stock price just last session, and is now a 12.2% discount to current levels. 

 

Two High-Octane Trade Ideas. One Simple Goal: Intraday Profits.

Dynamite Day Trading Signals delivers two same-day options trades every week — powered by proprietary intraday analysis and 43+ years of trading expertise.

But this isn’t just another stream of alerts.

It’s a structured plan with clear entry and exit points – designed for traders who want to act fast, trade smart, and wrap up gains before the closing bell.

No guesswork. No overnight exposure – Just two well-researched setups per week — whether you prefer buying premium or selling it.

And the results speak for themselves: subscribers have locked in +245.8% total profit over the last six months (since inception!).

👉 Start your one-month trial now for just $10, and be ready for the next trade alert.